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ABSTRACT 
 
Tuberculosis (TB) is caused by Mycobacterium tuberculosis and is one of the leading 
reasons of death by an infectious bacterial pathogen. The development of TB vaccines 
has been recognized as a major public health priority by the World Health Organization. 
In this study, a potential candidate antigen, ESAT-6 (6 kDa early secretory antigenic 
target) was fused with cholera toxin B subunit (CTB). Transplastomic lettuce plants 
were generated expressing these fusion proteins. Site-specific transgene integration 
into the chloroplast genome was confirmed by polymerase chain reaction and Southern 
blot analysis. In transplastomic leaves, expression levels of fusion protein (CTB-ESAT6) 
varied depending upon the developmental stage and time of leaf harvest with highest-
level of accumulation in mature leaves harvested at 6PM. Transplastomic CTB-ESAT6 
lettuce plants accumulated up to 0.75% of total leaf protein. Lyophilization increased 
CTB-ESAT6 protein content per gram of leaf material by 22 fold. Western blot analysis 
of lyophilized lettuce leaves showed that the CTB-ESAT6 fusion protein was stable and 
can be stored for prolonged period at RT. Hemolysis assay with purified CTB-ESAT6 
protein showed partial hemolysis of red blood cells and confirmed functionality of   
ESAT-6 antigen. GM-1 binding assay demonstrated that the CTB-ESAT6 fusion protein 
formed pentamers to interact with GM1 ganglioside receptor. The expression of 
functional Mycobacterium tuberculosis antigens fused to CTB in transplastomic plants 
should facilitate development of a cost-effective and orally deliverable TB vaccine with 
potential for long term storage at room temperature. 
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 INTRODUCTION 
 
 Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB), is one of the 
leading bacterial infections that is re-emerging due to drug resistant strains worldwide. 
The World Health Organization (WHO) estimates the global burden of TB in 2009 to be 
9.8 million incident cases with multi drug resistant TB(MDR-TB), growing at a rate of 
half a million cases every year (WHO 2010). According to statistics, an estimated      
250 000 (range, 230 000–270 000) had multi drug resistant TB in 2009. TB is also the 
leading cause of death in HIV-infected patients as Immuno suppression increases risk 
of reactivation of TB. The death toll caused by TB has steadily decreased in developed 
countries due to better health practices and antibiotic usage. But underdeveloped 
countries like Africa are still suffering from this punishing disease. The major reasons 
attributed to this rise are lack of health care, poverty, emergence of AIDS, malnutrition, 
spread of infection. 
 
Pathogenesis & survival of Mycobacterium tuberculosis 
 
 Tuberculosis is triggered by infection with Mycobacterium tuberculosis (MTB), a 
bacillus bacterium. It is a small, gram positive rod shaped bacterium with high lipid 
content. It is spread by aerosol droplets by the coughing of a patient with pulmonary 
tuberculosis and through inhalation of small sputum particles by an uninfected 
individual. Its symptoms are mainly associated with bloody sputum, fever, coughing and 
weight loss. MTB can affect any part of the body as it can escape the lung and enter the 
bloodstream. This results in systemic disease affecting many organs including 
gastrointestinal tract, spleen, bones, joints, liver, and brain. Systemic form of the 
disease is fatal and can cause death shortly.(Anne DeGroot 1999) 
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 Initially MTB on its entry in to the lungs reside in the macrophages. Initial 
development of TB brings about delayed type hypersensitivity response, characterized 
by the formation of small necrotic lesions comprising caseous centers. MTB 
multiplication is probably controlled while being encapsulated in these granulomatus 
lesions. T lymphocytes and mononuclear phagocytes of various levels of activation 
cause these lesions as a barrier to seal off the bacteria. This is the latent infection 
stage. It is effective until the immune system falters due to factors such as 
immunosuppression. The evasion mechanisms of tuberculosis have led to its survival in 
the human body. It has the ability to multiply in lung macrophages and also reduce the 
ability of macrophages to cause phagolysosome fusion that might lead to its death. It 
turns the immune system on self by causing inflammation of host tissue.  It secretes 
virulent factors that release lysosomal enzymes and TNF-α, responsible for tissue 
damage. Other cases where proteases like cathepsin D are believed to play a role in 
the liquefaction of granulomas. Interference with macrophage activation has been 
observed by producing factors such as lipoarabinomannan, a glycolipid that represses 
proliferation of T-cells. This reactivation from latency period has confounded scientist as 
there has been research on how this bacteria can persist in the body. Two genes acr, 
isocitrate lyase have been identified which could play a role in the persistence of this 
bacteria. 
 
Diagnosis and Treatment of Tuberculosis 
 
 The definition of infection of TB is limited to patients who convert from negative to 
positive on a skin TB test. PPD constituting mycobacterial proteins is injected in to the 
skin and tested for appearance of red rashes for positive skin test. No reaction in case 
of negative test. This test gives no information about active infection in case of patients 
who have been immunized with anti-TB vaccines and this is not specific to MTB, as 
other mycobacteria give a weak response. Sputum smear microscopy followed by 
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bacterial culture from patients, is employed for TB diagnosis.  Early identification aids in 
prevention of lung damage and spread of infection. Of the people infected with TB, only 
1% develop active TB infection. In developing countries, many people are already 
infected with MDR strains of TB. Drug combination therapy showed a success rate 
greater than 90% prior to MDR tuberculosis, even in AIDS patients. MDR tuberculosis is 
highly infectious and almost incurable with a mortality of 50%. TB is now becoming the 
leading cause of death among HIV infected patients killing with a greater rapidity. In the 
past, measures employed to control TB have involved the use of combinations of 
antibiotics. Currently, individually tailored combination of antibiotics is essential 
depending on the strain of MTB infection, due to many complications associated with 
multidrug-resistant strains. Surgical removal of the affected portion of the lung is 
necessary for severe cases of TB. A new effective control strategy by the WHO that is 
currently being implemented throughout the world is DOTS.  
 
Development of tuberculosis Vaccine 
 
 Bacillus Calmette Guerin (BCG) is an attenuated strain of Mycobacterium bovis 
and is the only available licensed vaccine against TB. Lack of toxicity has enabled It to 
be distributed worldwide. Many trials that evaluated BCG on the basis of protective 
immunity and age of vaccination have been inconsistent and variable, ranging from 0 to 
80 % efficacy. (Colditz et al. 1994; Brewer et al. 1995; Xing et al. 2006). BCG does not 
play a role in preventing the establishment of latent TB or reactivation of pulmonary 
disease in adults (Andersen 2007). BCG cannot be given in booster doses to establish 
protective immunity. 
 To remedy this, research groups are engaged in developing more efficient anti-
TB vaccines which may have the potential to replace BCG as a primary TB vaccine or 
act as an effective boosting vaccine (Derrick et al. 2004; Andersen 2007; Doherty et al. 
2007; Coler et al. 2009). Compared to attenuated live TB vaccines, subunit vaccines 
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offer several advantages including safety, efficacy and they are better suited for 
standardization (Agger et al. 2001; Tsenova et al. 2006). On the other hand, limitations 
include poor immunogenicity of purified antigens and restriction in the number of 
antigens exposed. This makes an immunostimulatory component all the more essential 
in an effective vaccine. 
 Many different fractions of MTB have been proposed as subunit vaccine 
candidates including surface components and secreted proteins. Some of the promising 
antigens are ESAT-6, Ag85B, MTB72F etc. The reasoning behind this has been that 
killed BCG vaccines has proven to be ineffective compared to attenuated vaccines. This 
led researchers to believe that active secretion of proteins can induce appropriate cell 
mediated response (Brodin et al. 2006). Any mycobacterial antigen which activates both 
CD4 & CD8 T - cells and imparts protective immunity is believed to be the ideal 
candidate for subunit vaccination against TB. Antigenic proteins actively secreted during 
the early phase of growth of MTB are best suited as potential candidates for subunit 
vaccines (Brodin et al. 2004). 
 
Early secretory antigenic target - 6 (ESAT-6) vaccine candidate 
 
 ESAT-6 (6 kDa early secretory antigenic target), a protein comprising 95 amino 
acid (aa) residues, is one such promising vaccine antigen candidate that was identified 
based on its immunogenicity from the culture filtrate of mycobacterial antigens, that can 
strongly elicit a specific T-cell response (Brandt et al. 2000). ESAT-6 has been 
established to be present in the RD-1 region in all virulent strains of MTB but its also 
striking that its absent in the attenuated BCG vaccine strain (Andersen et al. 1995). 
Hence ESAT – 6 could prove to be one of the components essential to treat this 
complex disease..  ESAT-6 was found in a complex with another protein CFP-10, a 
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 10 kDa protein and belongs to the ESAT-6 family (ESX-1). 23 ESAT-6 family members 
have been identified in M. tuberculosis strain H37Rv and has been shown to be located 
in 11 genomic loci.(Brodin et al. 2006). ESAT-6 and related mycobacterial proteins have 
shown to require a unique secretory apparatus encoded by genes flanking esxA and 
esxB, in its secretion from MTB.  
 Role of ESAT-6 in mycobacterial infection is controversial. Based on study of     
ESX-1 mutants, their involvement in the spread of  tubercle bacilli to neighboring cells 
has been established., ESAT–6 has been shown to be a virulent factor by inducing 
membrane pore formation in macrophages (Smith et al. 2008). Another report suggests 
that ESAT-6 can induce apoptosis in macrophages by activating caspase expression. 
Reports suggest that biological activity of ESAT-6  rests on the proper export of ESAT-6 
by its secretion machinery.(Pym et al. 2003) As ESAT-6 has shown to be recognized by 
infected TB patients with higher sensitivity, a diagnostic potential for ESAT – 6 is also 
being explored. In mice, vital T cell epitopes of ESAT-6 antigen have been distinguished 
to be P1,at  the N-terminus (residues 1–20)and another P6,at the C-terminus (residues 
51–70) (Brandt et al. 1996). In animal models such as guinea pig, mice,  ESAT-6 was 
used as a subunit vaccine and did not cause any toxicity.(Doherty et al. 2002).  It was 
reported to induce production of gamma interferon (IFN-γ), a marker for protective 
immune response (Agger et al. 2001; Kumar et al. 2010) with protective immunity 
comparable to BCG (Brandt et al. 2000). Many vaccine trials in animal models such as 
mice  The vaccines based on ESAT-6 antigen in combination with another 
mycobacterial antigen Ag85B have entered human clinical trials (van Dissel et al. 2010). 
 Mycobacterial antigens as subunit vaccines have been targeted by different 
delivery systems including recombinant viral vector system (Sereinig et al. 2006), 
recombinant bacterial vector system (Triccas 2010), lipoglycan - protein conjugate 
system (Hamasur et al. 2003). Here we plan to deliver tuberculosis antigens to the 
GALT – an integral part of the mucosal immune system. TB, being a respiratory 
disease, subunit vaccination targeting the mucosa is well disposed to initiate both 
mucosal and systemic immune response. In order to survive the extreme physiological 
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conditions of the gut, strategies have to be employed to protect the antigen and 
optimize dosage conditions to ensure antigen uptake. 
 
Cholera Toxin B subunit as a mucosal adjuvant 
 
 Cholera Toxin triggers diarrhea by colonizing the small intestine. Cholera toxin is 
characterized to be a AB5 toxin containing 2 subunits, one is a toxic 27 kDa A subunit 
exhibiting ADP ribosyl transferase activity and other is a nontoxic pentamer of 11.6 kDa 
B subunit, whose primary function is to binds to the A subunit and bring about the entry 
of the toxin into the intestinal epithelial cells (Daniell et al. 2001). Cholera toxin B 
subunit is a well researched mucosal adjuvant that has been reported as a carrier 
molecule for mucosal immune responses and oral tolerance (Langridge et al. 2010). It 
has been reported that adjuvanticity of CTB increases with coupling to antigens. This 
could be attributed to, one, better uptake of antigen across the mucosal linings. Two, 
efficient antigen presentation to dendritic cells and macrophages. Although there are 
some reports indicating that auto antigens coupling with CTB bring about oral tolerance, 
it is believed that the nature of the antigen fused to CTB plays an important role in the 
manner of immune response.(Langridge et al. 2010) ESAT-6 is an established 
immunodominant T-cell antigen. I believe CTB fused with ESAT-6,TB antigen could 
potentiate systemic and mucosal immune response. Plant vaccines are highly efficient 
delivery vehicles as they are capable of transporting large amount of antigen in an 
encapsulated form. 
 
Chloroplast genetic engineering and its advantages 
 
 Expression of the TB antigens in plants through chloroplast transformation has 
several advantages over other production systems. Transplastomic plants have not 
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reported gene silencing, in spite of accumulating >100-fold higher transcripts compared 
to nuclear transgenic plants(Daniell et al. 2009). High levels of expression (up to 72%) 
of several biopharmaceutical proteins and vaccine antigens have been attained via the 
chloroplast system (Bally et al. 2009; Ruhlman et al. 2010). Hyper-expression of the 
biopharmaceuticals in chloroplast facilitates cost effective production without laborious 
purification methods and cold chain issues. In spite of their prokaryotic origin, plant 
chloroplasts are recognized to develop proper disulphide bonds (Ruhlman et al. 2007; 
Bally et al. 2008)and other post-translational modifications such as lipidation (Glenz et 
al. 2006).The functionality of chloroplast-derived vaccine antigens has been validated 
by several assays including the macrophage lysis assay (Koya et al. 2005), GM1-
ganglioside binding assay (Daniell et al. 2001; Davoodi-Semiromi et al. 2010) and 
immune response to challenge by pathogens (Arlen et al. 2008) . In comparison to 
mammalian expression systems, there is minimal risk of animal or human pathogens 
contaminating the vaccines (Koya et al. 2005). Additionally, chloroplasts demonstrated 
transgene containment preventing escape through pollen because of maternal 
inheritance of the plastid genome (Daniell 2002; Daniell et al. 2009). Recombinant 
ESAT-6 has been expressed in transient plant production systems such as  potato virus 
X vector based system (PVX), tobacco mosaic virus vector based system ,  
agrobacterium mediated transformation (Rigano et al. 2004; Zelada et al. 2006; 
Dorokhov et al. 2007). But no stable integration of transgene for TB antigens in 
chloroplast has been obtained yet. 
 
Oral delivery of vaccine antigens 
 
 In animal trials, many plant oral vaccines expressing foreign proteins fused to 
CTB have shown to be protected against degradation by stomach enzymes and offer 
protective immunity against disease states (Ruhlman et al. 2007; Arlen et al. 2008; 
Davoodi-Semiromi et al. 2010). Oral delivery of bioencapsulated coagulation factor IX 
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has shown to prevent inhibitor formation thereby avert anaphylaxis in hemophilia B mice 
(Verma et al. 2010). The most important advantage associated with oral delivery of 
plant antigens is bioencapsulation of antigens. Any antigen that is orally delivered 
undertakes risk of being degraded by the enzymes present in the stomach. This can be 
prevented by bioencapsulation via plant cells as they can prevent degradation of 
antigen by digestive enzymes. In a report of CTB-GFP oral delivery, transgenic leaf 
material has been administered to mice. The results observed the presence of CTB in 
the intestinal wall and fluorescence emitted by GFP in mouse intestinal sections, liver, 
and spleen (Limaye et al. 2006). Many edible crops have been reported to be 
developed for expressing vaccine antigens such as tomato, potato, carrot. But Lettuce 
is an ideal system to develop chloroplast engineered vaccines, as it is rich in 
chloroplasts.  Lettuce (Lactuca sativa) was chosen as an alternative to tobacco for 
expression of TB vaccine antigens due to its many advantages such as it being an 
edible crop, its leafy nature and commercial importance.  According to U.S department 
of agriculture statistics for 2009, about 32500 plants have been planted throughout. 
Yield of lettuce has b  345 cwt per acre of lettuce plants. Hence we can see how lettuce 
vaccine antigen could be feasible on a larger scale. 
 In this study, ESAT - 6 fused with CTB was expressed in lettuce chloroplasts to 
explore the possibility of chloroplast as an efficient bioreactor for oral delivery of vaccine 
antigens against TB. The expression levels of TB antigens were analyzed using western 
blot analysis. Lyophilization was performed on lettuce leaves for increasing antigen 
content. GM-1 binding ELISA assay confirmed binding affinity of   CTB – ESAT6 to GM-
1 receptor. Hemolysis assay demonstrated pore forming ability of CTB – ESAT6 in red 
blood cell membranes. 
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MATERIALS AND METHODS 
 
Chloroplast Vector Construction 
 
 Lactuca sativa long flanking plastid transformation vector (provided by Dr.verma) 
(pLSLF) was constructed using primers derived from regions of known conservation in 
the Nicotiana tabacum plastome to amplify cognate sequences from the Lactuca sativa 
plastome. Lettuce flanking sequence vector (pLSLF) was designed to integrate the 
transgene into transcriptionally active spacer region between trnI and trnA genes as 
explained  previously (Ruhlman et al. 2007; Verma et al. 2008).The gene cassette 
comprising promoter Prrn and rbcl from lettuce chloroplast genome and selectable 
marker aadA gene was built into pBSSK+ vector and cloned into pLSLF. pLD-5′-UTR-
CTBPins(Ruhlman et al. 2007)  vector was used  as the template to amplify the CTB 
sequence. Further, the ESAT-6 sequence was amplified using sequence-specific 
restriction-site flanking primers and Mycobacterium tuberculosis genomic DNA as the 
template. The CTB- ESAT6 gene was ligated in to pLSLF to create pLS-CTB-ESAT6 
vector along with psbA promoter and 5′ and 3′ UTR from lettuce regulatory regions. To 
facilitate proper folding of protein, both fusions (CTB-ESAT6 and CTB-MTB72F) had the 
GPGP hinge in between fusion proteins for reducing the steric hindrance. 
 The chloroplast transformation vector DNA was transformed in to competent cells 
Alpha-Select Gold Efficiency (Bioline) using CaCl2 method and E.Coli colonies were 
grown overnight on a pate containing ampicillin (100 mg/ml). The colonies were 
selected on the next day  in  LB broth containing ampicillin. These colonies were then 
screened by colony PCR to choose recombinant clones.  Protein extraction ws 
performed on the positive clones by sonication and Immuno blot analysis using CTB 
antibody was performed as described later in detail. 
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Preparation of Gold Particles for coating plasmid DNA 
 
 Gold particles (150 µl) and 1 mL of 100% ethanol were mixed together to obtain 
even suspension in a 1.5 mL eppendorf tube. This mixture was centrifuged at 14,000 
rpm for one minute. Follwing centrifugation, the pellet was retained and was washed in 
1 mL of 70% ethanol. This gold particle suspension was left for twenty minutes in a 
vortexer at 4 °C. Centrifuging at 5,000 for three minutes was followed by removal of 
supernatant and the gold particles were vortexed with 1 mL of distilled water.This was 
allowed to incubate at room temperature for one minute and centrifuged again at 5,000 
rpm for two minutes. This procedure was repeated three times to ensure complete 
washing (Kumar and Daniell 2004). After washing steps, the gold particles were finally 
resuspended in sterile 100% ethanol. This was stored in ice for final use during 
bombardment. 
 Based on earlier optimizations, 10 µg of plasmid DNA was coated on the  50 µL 
of gold particles in a 1.5 mL micro centrifuge tube. There were further additions of 100 
µL of pre filtered 2.5 M CaCl2 and 40 µL of 0.1 M spermidine common stock for optimal 
binding of DNA to the gold particles. The supernatant was removed and complete 
removal of ethanol was ensured. The pellet was washed three times in 300 µL of 
absolute alcohol. The DNA-coated gold particles were resuspended in 100 µL of 100% 
ethanol. This mixture could result in ten shots of bombardment comprising of 10 µL of 
DNA-coated gold particles were loaded onto macro carriers and allowed to dry in the 
laminar flow hood. Then macrocarriers were loaded on to the bioliistic particle delivery 
system. 
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Bombardment of Lettuce leaf tissue 
 
 Chloroplast transformation including bombardment and regeneration was carried 
out as described previously (Kumar et al. 2004; Verma et al. 2008). Sterile fully 
expanded leaves of untransformed lettuce plants (wildtype) were placed on MS medium 
with adaxial side up for lettuce (Lactuca sativa). The leaves were bombarded with gold 
particles coated with plasmid DNA of pLS-CTB-ESAT6 using the biolistic device 
PDS1000/He (Bio-Rad). The macrocarrier with the DNA-gold coated particles were 
placed on the macrocarrier holders in the gene gun. The bombardment was performed 
using 900 psi rupture disks and at a target distance of 6cm between the leaves and the 
coated particle as optimized earlier. Then the leaves were incubated in 25°C in the dark. 
 
Regeneration and Selection of Transplastomic Shoots 
 
 After incubation at 25°C in the dark for 2 days, the leaves were cut into 5x5 mm
2
 
pieces and transferred on  to RMOP media – 1 litre,  comprising of 1 packet of MS basal 
salt mixture, , 100 mg myoinositol, B5 vitamins ( 1mg pyridoxine,1 mg Nicotinic 
Acid,10mg of thiamine hydrochloride ,1 mg of glycine) , 30 g of sucrose, 200 µl of 1 
mg/mL-  0.2 mg BAP, 100 µL of 1 mg/mL – 0.1 mg NAA. The pH was adjusted to  5.8 
using 1NaOH.  We also added  6g of phytagar (phytablend ) for solidification before 
being autoclaved and cooled for pouring into plates containing 50 µg/mL of 
spectinomycin making sure the bombarded side faces the  medium. The Petri dish was 
sealed using parafilm and placed in the culture room till appearance of putative 
transgenic shoots. This process is second round selection and the shoots are allowed to 
develop for 4-8 weeks. The third round of selection was performed when the shoots are 
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placed in  half strength MS media (one packet of MS salt mixture along with 30 g of 
sucrose to 2 L of sterile distilled water; the  pH was adjusted to 5.8 using 1N NaOH; 6 g 
of phytoblend ) with 50 µg/mL spectinomycin. Once roots develop, they are ready to be 
transferred to incubator. 
  Rooted plants were transferred to Jiffy peat pots and placed in incubator for 
acclimatization. After considerable growth, plants were moved to green house for 
maturation, flowering  and seed production. 
 
Confirmation of site specific Transgene Integration  
 
 To confirm the transgene cassette(s) integration into the chloroplast genome, 
genomic DNA was extracted from leaf tissues of spectinomycin resistant and wild-type 
untransformed plants using Qiagen DNAeasy Plant Mini Kit (Qiagen,Valencia,CA) using 
the manufacturer’s protocol. Leaf material from both incubator plants and in vitro 
greenhouse plants were ground with liquid nitrogen into fine powder. In the final step, 
the pellet was washed using 70% ethanol and centrifuged for ten minutes at 14,000 
rpm. The pellet  was air dried till we lost any scent of ethanol. Then the pellet was 
dissolved in 100 µL water or TE buffer depending on downstream purposes. In order to 
visualize the bands, the DNA samples were loaded on a 0.8% agarose gel. The 
concentration of the DNA was determined by a Nano drop 2000.  
 PCR analysis was performed using the primer pairs mentioned below 
 16SF (5'-CAGCAGCCGCGGTAATACAGAGGA-3') and 3M (5'- 
CCGCGTTGTTTCATCAAGCCTTACG -3'). Additionally, to validate the integration of 
transgene of interest, another primer pair 5P (5'-CTGTAGAAGTCACCATTGTTGTGC-
3') and 2M (5'- TGACTGCCCAACCTGAGAGCGGACA -3') was used. :, 5 µL of 10X 
Buffer, 1 µL of DNA(depending on concentration), 2.5 µL of MgCl2, 1 µL of dNTP’s, 1 µL 
of forward primer, 1 µL of reverse primer, 1 µL Taq polymerase, and 37.5 µL of sterile 
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H20. Initial denaturation cycle was set at 94°C for 5 minutes following amplification for 
thirty cycles of the following program: denaturation - 94°C for 30 seconds, annealing -   
61°C  for  30  seconds  and extension - 72°C  for  1  minute  and  30  seconds.The last 
step was the fiinal extension of five minutes at 72°C at the end of PCR process. 
 
Restriction Digestion of Genomic DNA 
 
 The transformed and untransformed samples containing equal concentration of 
DNA were digested with HindIII restriction enzyme in a reaction containing:(20 µL )1.5 
µg of DNA, 4 µL of 10X Buffer 4 (New England Biolabs), 1 µL of HindIII (New England 
Biolabs), and 15 µL sterile distilled H20 to make up the volume of 40 µL of total reaction 
volume. The digestion reaction was performed overnight at 37°C. 
 40 µL reaction volume digestion products were loaded on a 0.8% agarose gel 
and was run for 4-5 hours at 80 volts. After electrophoresis, the gel was visualized 
under UV light periodically to check the size of the products and if they were separated 
enough. After sufficient separation, the gel was depurinated with 0.3N HCl for 15 
minutes (the color of the dye usually became yellow. This was followed by three washes 
with sterile H20. The gel was immersed with in transfer buffer (0.4N NaOH, 1M HCl) for 
20 min. DNA was transferred from the agarose gel on  to Nylon membrane. This was 
based on the Rapid Downward Transfer System, Schleicher &  Schuell) protocol. 
Initially, one sheet of prewet filter paper in transfer buffer was placed in the stack tray.  
The gel was placed upside down upon the sheet. Nylon membrane (N+-Bond, 
Amersham Biosciences, USA) was pre soaked and placed on the gel. Followed by 
some application of transfer buffer, three sheets of prewet filter paper were placed on 
top. This was followed by placement of a stack of paper towels cut to fit the gel 
dimensions. In order to remove any air bubbles, we employed Rolling stick. A cover with 
a heavy weight on top was placed prevent evaporation, increase capillary action. The 
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transfer was performed overnight at room temperature. After transfer, it was rinsed with 
transfer buffer twice for five minutes each. This step was followed by air drying the 
membrane.  UV Strata linker 2400 at the C3 setting semi wet membrane crosslink setup 
was used to crosslink the membrane. 
 
Generation of Flanking Probe 
 
 The flanking probe was obtained by digesting Lettuce chloroplast flanking 
sequence pLS -CT DNA with BamH I and Bgl II enzyme and generating 1.3 kb fragment 
This product was eluted by loading it into a 0.8% agarose gel. The bands were excised 
after visualization using Bio Rad Gel Doc 2000. The gel fragments were extracted with 
the QIAquick Gel Extraction Kit (Qiagen) by following the manufacture’s protocol. 
Forty five micro liters of the eluted DNA fragment was denatured at 95°C for 5 min and 
immediately placed on ice for 2 min. Random primer labelling kit was used to produce 
high specificity probe as per manufacturer’s protocol. The denatured probe was added 
to the DNA labeling beads and the tube was mixed gently by flicking the tube. Two or 
three microliter of radioactive 32P (depending on the time and half life) was  added to the 
probe mixture the mixture was incubated at 37°C for one hour. G50 (Probe Quant) 
microcolumns were used to purify the radiolabelled probe.  The column was quickly 
vortexed for the resin mixing. The column was centrifuged at 3000 rpm to remove the 
solution in the resin. The probe DNA was added to the column and centrifuged at 3000 
rpm for 3 min to purify the probe DNA. 
 
Hybridization and Autoradiography 
 
 The membrane that was crosslinked and stored was placed in Quick Hyb 
solution (Stratagene). This was pre -
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for 1 hour. 100 µL of salmon sperm DNA was added to labeled probe and then the 
probe was boiled for five minutes. After boiling, it was added to the hybridization bottle. 
This hybridization process was performed at 65°C. Next day, the membrane was 
washed twice  with high stringency wash buffer I (2X SSC, 0.1% SDS)  followed  by  
washing  with  low stringency wash  buffer II  #2  (0.2X  SSC,  0.1%  SDS) for  fifteen 
minutes each. The membrane was allowed to air dry behind the plastic shield. The 
radioactive membrane was wrapped with saran wrap. The membrane was exposed to 
X-ray film in a cassette in – 80°C for 2 days or more depending on the radioactivity 
counter. The exposed film was developed in a automated film developer.  
 
Analysis of transgene Integration  
 
 In order to confirm maternal inheritance, seeds harvested from the CTB - ESAT6 
plants transplastomic plants were germinated on ½ MS salt supplemented with 
spectinomycin (100mg/l for lettuce). Sterilization of seeds was performed with 1.5% 
bleach, followed by thorough rinsing in distilled water.. Seeds from untransformed plants 
were also grown in the same plate. The growth of the plants was observed after 10 
days. 
 
Extraction of Plant leaf protein 
 
 Transformed and untransformed leaves (～100 mg) were ground in liquid 
nitrogen with a mortar and pestle followed by extraction with a mechanical pestle in 200 
µl of extraction buffer (200 mM Tris-HCl, pH 8.0, 100 mM NaCl, 0.1%SDS, 400mM 
sucrose, 0.05% Tween 20, 2mM PMSF and proteinase inhibitor cocktail (roche)). The 
leaf extracts were then centrifuged for 5 min at 10,000 rpm to separate out the 
supernatant and pellet the insoluble plant material. The pellet was resuspended in 
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buffer and sonicated in ice for 10s pulse for a min. Bradford assay was performed to 
detect total protein concentration using Protein Assay Dye Reagent Concentrate (Bio-
rad).Standard curve for this assay was generated with Bovine serum Albumin (BSA) 
with dilutions ranging from 0.8 mg/ml to 0.025 mg/ml. All samples were loaded in 
duplicate. Protein Assay dye was dilutes and absorbance was measured at 595 nm. 
 
Detection of fusion protein using western blot analysis 
 
 To quantify the expression of the fusion protein ~one hundred milligram (mg) of 
the leaf samples at different developmental stages (young, mature and old) or at 
different time points  (10 a.m., 12 p.m. and 6 p.m.) during the day were collected from 
plants exposed to regular lighting pattern (16h light and 8h dark). Homogenate, 
supernatant and pellet fractions were boiled for 5 min in sample buffer (0.5M Tris-HCl, 
25% glycerol, 10% SDS, 0.5% Bromophenol blue and β-mercapto ethanol) and 
separated by sodium dodecyl sulfate - polyacrylamide gel electrophoresis (SDS-PAGE) 
(Bio-Rad). The separated proteins were then transferred on to a nitrocellulose 
membrane in a transfer cassette (Bio-Rad) at 85V for 1 hour. After blocking with 
phosphate-buffered saline (PBS),0.1% Tween 20, 3% milk powder (PTM), the 
membrane was incubated with anti-CTB primary antibody (1:4000, Sigma, St. Louis, 
MO, USA) diluted in PTM followed by 1:5000 horseradish peroxidase (HRP) - 
conjugated goat anti-rabbit secondary antibody (Southern biotech, Birmingham, AL, 
USA) for 1 hour 30 minutes. A Super Signal West Pico HRP Substrate Kit (Pierce, 
Rockford, IL, USA) was used for autoradiographic detection.  
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Densitometry analysis  
 
 To quantify the expression of fusion protein, in case of the lettuce plant, we 
performed densitometric analysis on the immunoblots with CTB antibody. Known 
concentrations of purified CTB (Sigma) were used as standards (25, 50, 75 and 100ng) 
to create a standard curve. Total protein concentration was measured using Bradford 
assay (Biorad). Fusion protein was loaded in different concentrations of total protein and 
their integrated Density values (IDV) was measured using Alphaimager 2000 and 
analyzed using Alphaease software. The percentage of fusion protein (%Total leaf 
protein) and amount of transgenic protein (µg/g) is calculated based on the formula 
published earlier (Verma et al. 2008). 
 
GM1 - Ganglioside Receptor Binding Assay: 
 
 GM -1 ganglioside (Sigma G-7641) and BSA (control) was coated at a 
concentration 3 µg/ml in bicarbonate buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) 
on to a 96 well plate at 4ºC overnight. Washing was performed thrice with 1X PBST and 
water. The wells were then blocked with 200 µl of phosphate-buffered saline (PBS) - 
0.1% Tween - 3% milk powder (PTM) for 2 hours at 37ºC followed by washing thrice 
with 1x PBST and water.CTB protein standards, Untransformed plant leaf TSP and 
transformed leaf TSP diluted in ELISA coating buffer were coated on to the plate in 
different concentrations and incubated for 2 hours at 37ºC. The plate was washed again 
as stated above and incubated with anti - CTB primary antibody (1:3000 dilution) for 1 
hr at 37 ºC. Further, the plate was incubated with secondary HRP-conjugated goat anti-
rabbit IgG in 1:4000 dilution. Following washing with 1X PBST and water thrice, 100 µl 
of 3, 3, 5, 5-tetramethylbenzidine substrate was added and incubated for 10 to 15 min at 
room temperature. The reaction was terminated by adding 50µl of 2 N H2SO4 per well 
and the absorbance was read on a plate reader at 450 nm. 
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Antibody Affinity purification: 
 
 Total leaf protein of CTB – ESAT6 was extracted with 2X PBS, 0.1% Tween – 
20,pH 8, proteinase inhibitors and sonicated (Sonicator 3000 Misonix) for 1 min in ice. 
Supernatant was obtained after centrifuging for 5 min at 2000 rpm. Pre- clearing of the 
supernatant was performed with 100mg of Protein A Sepharose CL-4B (GE Healthcare) 
beads along with protease inhibitors (Roche) overnight at 4ºC. Rabbit anti-cholera toxin 
B subunit polyclonal antibody (Abcam, ab34992) was coated on to washed protein A 
beads in a ratio of 50µg: 200µl in 1X PBS overnight at 4ºC for antibody binding to 
beads. Washes were performed with 1X PBS followed by 0.1M sodium borate buffer 
(pH 9). 20mM Dimethyl pimelimidate DMP (sigma, D8388) crosslinker in sodium borate 
buffer was added to the bead- antibody mixture and incubated for 30 min at room 
temperature twice. Washes were continued with 50mM glycine pH 2.5 followed by 1X 
PBS. Cross linked antibody was added to the precleared supernatant and incubated 
overnight at 4 ºC. Elutions were performed with 100 mM glycine buffer, pH 2.5 in 100 µl 
volume with 10µl of 1M Tris-HCl pH 9 for neutralization at room temperature. All Elution 
fractions were analyzed by Biorad Bradford assay and nanodrop spectrophotometer via 
absorbance at 280nm for total protein concentration in mg/ml. Silver staining was 
performed to detect purity % 
 
Silver staining: 
 
 SDS-PAGE gel (12%) was fixed using a fixative (50% methanol, 12% acetic acid) 
overnight at 4ºC and washed twice with 50% ethanol. The gel was pretreated with 
0.02% sodium thiosulphate solution (Na2S2O3) for 1 min and then washed thrice in 
distilled water for 1 min each. Gel was stained with Silver nitrate solution (0.2% silver 
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nitrate in formalin) for 20 min. The gel was rinsed twice in distilled water for 1 min and 
developer solution (2% Na2CO3, 0.0004% Na2S2O3, formalin) was added. Gel was 
shaken to observe bands in developer solution. Developer solution was replaced after 5 
min and reaction was stopped with 1% acetic acid as soon as protein bands were 
observed.  
 
Lyophilization:  
 
 CTB – ESAT-6 lettuce leaves were frozen in liquid nitrogen and then lyophilized 
in Freezone Benchtop Freeze Dry Systems(Labconco) in vacuum for 2 days at -50ºC at 
0.036 mBar. After lyophilization, they were stored at room temperature in vacuum for 
few days. The samples were ground to fine powder in waring blender and further testing 
was performed. 
 
Hemolysis Assay: 
 
 To test the hemolytic activity of the ESAT-6 protein, hemolysis assay was 
performed with affinity purified CTB – ESAT6 fusion protein. Pore formation in red blood 
cell membranes can be measured by hemolysis assay as shown previously (Smith et al. 
2008). Affinity purified CTB – ESAT-6 was solubilized with 0.1M KCl – HCl for 1 min 
followed by neutralizing with 50mM Tris - HCl, pH 8 as described earlier (Ruddock et al. 
1996; Tinker et al. 2003). After solubilization, CTB-ESAT6 fusion protein was mixed with 
sheep red blood cells (1 x 109 cells) in a micro centrifuge tube in the ratio 1:2 and 
allowed to incubate at 32ºC for 2 hours. As controls, non solubilized CTB-ESAT6, 
distilled water and PBS were incubated with sheep red blood cells in the same ratio and 
under same conditions. The cells were then resuspended and centrifuged for about 7 
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min at 4000 rpm. Supernatants were loaded on to a 96 well plate and absorbance of the 
supernatants was read at 405 nm. 
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RESULTS 
 
Construction of lettuce chloroplast transformation vectors containing TB antigen 
 
 The lettuce chloroplast vector pLS-CTB-ESAT6 harboring CTB-ESAT6 was 
created (Fig. 1a). CTB-ESAT6 contained GPGP (Gly Pro Gly Pro) hinge in the middle of 
fusion proteins to assist in correct folding of each protein by lowering the steric 
hindrance. The lettuce vectors contained flanking sequences 16S/trnI and trnA/23S  
(Fig. 1a) to facilitate recombination into the native chloroplast genome. The fusion gene 
cassettes were regulated by endogenous psbA promoter and 5ʹ untranslated region 
(UTR) to achieve higher levels of expression due to the presence of multiple ribosome 
binding sites (Fernandez-San Millan et al. 2003; Ruhlman et al. 2010). The psbA 3ʹ UTR 
located at the 3ʹ end of the introduced gene cassette conferred transcript stability (Stern 
et al. 1987). The endogenous constitutive 16S rRNA promoter (Prrn) was employed to 
regulate expression of the aadA (aminoglycoside 3' adenyltransferase) gene with a 
GGAG ribosome binding site upstream of the start codon AUG (Dhingra et al. 2006) to 
confer spectinomycin resistance. The final chloroplast transformation vector pLS-CTB-
ESAT6 was sequenced and used for transformation studies. 
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Figure 1: Vector construction for chloroplast transformation.  
(a) pLS - CTB - ESAT6 vector. (b) Schematic diagram of expected products 
from digestion of the untransformed lettuce chloroplast genome respectively for 
the flanking sequence hybridization probe. (c) Immunoblot analysis of CTB-
ESAT6  transformed E.coli cells for expression of CTB – ESAT6.(N – 
untransformed e.coli, P – CTB standard(50  ng); 1-6 – transformed CTB – 
ESAT6 expressing E.coli; B – Blank; M- Marker.  
 
Confirmation of site specific transgene integration by PCR analysis 
 
 Four spectinomycin resistant lettuce shoots per forty bombardments were 
recovered with pLS-CTB-ESAT6 vector coated on gold particles. Site specific transgene 
integration of independent spectinomycin resistant shoots was verified by polymerase 
chain reaction (PCR) using 16SF/3M and 5P/2M primer pairs in lettuce. The 16SF 
primer anneals to the native chloroplast genome within the 16S rRNA gene whereas 3M 
primer anneals to the aadA gene (Fig.1a). PCR reaction with 16SF/3M primers 
generated a 2.77 kb fragment in lettuce CTB-ESAT6 transplastomic lines (Figure 2a, 
Lanes: 1-4), which should be obtained only if site specific integration had occurred. 
Nuclear transformants, mutants and untransformed plants did not show any PCR 
product (Figure 2a, Lane: N). Nuclear transformants could be distinguished because 
16SF will not anneal and mutants were identified because 3M will not anneal and thus 
eliminates shoots that have nuclear integration or spontaneous mutation of the          
(c)
(c) 
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16S rRNA  gene. The integration of transgene cassette was further tested by using 
5P/2M primer pair. The 5P primer anneals to the aadA gene upstream of CTB-TB 
antigen fusion gene cassette whereas 2M anneals to the trnA gene (Fig.1a). The 5P/2M 
primer pair generated a 2.53 kb PCR product in CTB-ESAT6 lettuce transplastomic 
lines respectively while no amplification was observed in untransformed plants as 
expected (Fig. 2b). 
 
  
Figure 2 : PCR analysis of lettuce transplastomic plants using (a) 16SF/3M primer       
(b) 5P/2M primers 
 (WT, untransformed plant; Number 1 to 4, transformed plants; 5, positive control; M, 
DNA ladder) 
 
Evaluation of homoplasmy in transplastomic plants by Southern blot analysis  
 
 Following PCR analysis, transplastomic plants were subjected to two additional 
rounds of selection (second and third) to promote homoplasmy. Southern blot analysis 
was performed to determine homoplasmy or heteroplasmy and to supplement the PCR 
confirmation of site specific transgene integration. The flanking sequence probe       
(1.13 kb in lettuce Fig. 1b) allowed detection of site-specific integration of the gene 
cassette into the chloroplast genome as it hybridizes with the trnI and trnA genes. The 
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transformed chloroplast genome digested with HindIII produced fragments of 11.49 kb 
for pLS-CTB-ESAT6 (Fig.1a) when hybridized with flanking sequence probe. The 
untransformed lettuce chloroplast genome digested with HindIII produced a 9.11 kb 
fragment respectively confirming that these plants lacked foreign genes (Fig.1a). The 
flanking sequence probe helps us identify if homoplasmy of the chloroplast genome was 
achieved through more rounds of selection. Absence of 9.11 kb fragment in lettuce 
CTB-ESAT6 transplastomic lines respectively confirmed homoplasmy (within the 
detection limits of Southern blot) and stable integration of foreign genes into the 
chloroplast genome (Fig 3). Plants confirmed by Southern analysis were transferred to 
jiffy pellets and placed in 16hr light/8hr dark cycle incubator until they were acclimatized.  
11.49Kb
1              2              3           4           WT
9.11Kb
 
Figure 3: Southern blot analysis of lettuce CTB-ESAT6 homoplasmy transplastomic 
plants 
 (WT, untransformed plant; Number 1 to 4, transformed plants). 
 
Selection and Generation of Transplastomic Plants 
 
 Transplastomic shoots were selected and generated by the use of RMOP 
selection media for lettuce with spectinomycin (Figure 4 A). Upon determination of 
positive transformants by PCR analysis, further selection and generation of 
transplastomic shoots was continued (Figure 4 B). For rooting of the plants, ½ MS 
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selection media containing spectinomycin was used (Figure 4 C).  The in vitro plants 
were confirmed homoplasmic by Southern Blot analysis. Later they were transferred to 
green house where they matured and seeds were collected  
 
 
Figure 4:  Selection of transplastomic plants  
 (A) Four to eight weeks after bombardment, transplastomic shoots can be seen on 
RMOP selection medium. (B) The second round of selection leaves from PCR positive 
transformants are transferred on to spectinomycin containing RMOP selection medium. 
(C) The third round of selection, shoots that were regenerated are transferred to ½ MS 
selection medium and rooting takes place in ten days.  
 
Analysis of transgene segregation  
 
 Seeds collected from only T0 CTB - ESAT6 transplastomic and untransformed 
lettuce plants were germinated on ½ MS medium with spectinomycin in the same plate. 
All T1 CTB-ESAT6 lettuce seeds germinated and developed into uniformly green plants. 
This lack of Mendelian segregation of genes confirmed maternal inheritance of 
transgenes. None of the untransformed seeds germinated on the selection media. 
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Further, after transfer to green house, all T1 plants flowered, set seeds and showed 
similar phenotype when compared to T0 and untransformed plants. 
 
 
   
 
 
 
 
 
Figure 5: Analysis of transgene integration  
(a) Maternal inheritance was confirmed with Wild Type (WT) vs. T1 seedlings. (b) 
Normal phenotype of transplastomic plants 
 
Characterization of the Chloroplast-Derived CTB- ESAT6 protein  
 Expression of the fusion proteins ESAT-6 were analyzed by immunoblots with 
different extraction fractions of leaf extracts using anti-CTB polyclonal antibody. Under 
reducing conditions, blots probed with anti CTB polyclonal antibody revealed CTB-
ESAT6 (CTB-ESAT6-Ls), the monomer form of fusion protein corresponding to 23 kDa 
was observed (Fig. 6a). Lettuce CTB-ESAT6 plants showed an additional lower band of 
about 15 kDa with anti–CTB antibody (Fig.6a). 
 
 
 
(b) (a) 
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Figure 6:  Immunoblot analysis under reducing and nonreducing conditions. 
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Figure 7:  Immunoblot analysis under reducing and nonreducing conditions 
Different leaf extraction fractions analyzed using CTB antibody (a) reducing conditions 
(b) :pentameric form of CTB-ESAT6 is shown along with pentameric form of CTB 
standard.( WT, – wildtype lettuce leaf protein, CTB- CTB purified protein (c) Immunoblot 
analysis with ESAT6 antibody ( WT, N – wildtype lettuce leaf protein; 1,2,3 - CTB-
ESAT6 plant protein). 
 This band might have been formed by proteolytic cleavage of fusion protein due 
to the presence of putative protease-sensitive sites. Since, the band is larger than CTB 
protein size (11.6 kDa), cleavage should be in ESAT-6. Analysis of different extraction 
fractions of fusion protein CTB-ESAT6 from lettuce indicated that most of the fusion 
protein existed in soluble form. Some of the protein was also detected in pellet under 
our experimental conditions (Fig. 6a). 
 We performed Peptide Cutter analysis the ExPASy server on ESAT-6 sequence 
to predict protein cleavage sites (Gasteiger E. et al. 2005). Peptide Cutter identified 
several cleavage sites closer to N-terminus of ESAT-6 (~25 amino acid) indicating a 
higher probability of cleavage in ESAT-6 protein.  
 
 
 
(c) 
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Table 1: Possible cleavage sites of CTB - ESAT6 using peptide cutter software. 
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Quantification of CTB–ESAT6 fusion protein in transplastomic lettuce plants by 
densitometry  
 
 Immunoblots of different extraction fractions of CTB–ESAT6 lettuce 
transplastomic plants indicated the presence of fusion protein in both supernatant and 
pellet (Fig.6b). Quantification of CTB-ESAT6-Ls fusion protein by ELISA couldn’t be 
correlated with western analysis. Therefore, CTB-ESAT6-Ls expression levels were 
determined on western blots by comparing homogenate fraction with known quantities 
of purified CTB and analyzing them by spot densitometry. Linearity of the standard 
curve was established using 25, 50 and 75 ng of purified CTB, enabling the estimation 
of CTB-ESAT6 expression (Fig. 7b). In lettuce, CTB–ESAT6 accumulated up to 0.75% 
of total leaf protein (Fig 7a). Mature leaves showed highest expression followed by 
young leaves (Fig. 7c). Old leaves showed lowest level of expression probably due to 
senescence and proteolytic activity. Similarly different time points of harvest were 
analyzed using densitometry. We observed an increasing trend from morning to evening 
with highest expression levels of fusion protein at 6 PM (Fig.7d). One of the limitations 
in oral delivery studies is the low level of expression of protein. 
 
 
 
 
 
 
 
Figure 8:  Quantification of Chloroplast-Derived CTB-ESAT6 expression 
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Figure 7:   Quantification of Chloroplast-Derived CTB-ESAT6 expression 
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(a) Bacterial CTB protein of known concentrations were loaded as standards and  
different concentrations of transgenic protein were evaluated with anti - CTB antibody 
Lanes 1,2,3,4 : CTB standards 25 ng, 50 ng, 75 ng,100 ng  lane 5,6,7 young, mature, 
old. (b) Standard curve was plotted with alpha ease software. Quantification of CTB-
ESAT6 (Ls) in T0 lettuce transplastomic plants at different developmental stages and 
harvesting time by densitometry. (c) Expression levels of lettuce CTB-ESAT6 (Ls) in 
percent TP at different developmental stages. (d) Expression levels at different 
harvesting time points. (1, 2, 3 – Transplastomic lines) 
 
Affinity of plant-derived CTB-ESAT6 for GM1-ganglioside receptor 
 
 To evaluate whether CTB-ESAT6 fusion protein produced in lettuce retained its 
biological function of binding to the GM1 receptor, we performed GM1-binding ELISA 
assay. A pentameric structure of CTB protein is required for binding to its receptor GM1-
ganglioside invivo (Tsuji et al. 1995; de Haan et al. 1998). CTB- ESAT6 plants along 
with purified CTB protein showed strong binding affinity to GM-1 (Fig. 8). Untransformed 
plants and bovine serum albumin (BSA) didn’t show binding to the GM1 receptor(Fig 8).  
 
Figure 9: Ganglioside GM1 ELISA binding assay 
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 Functionality of CTB was confirmed based on its binding affinity to Ganglioside GM1 
(E1,E2 - CTB–ESAT6 (Ls) total protein (15µg); WT - Wild type lettuce leaf protein 
(15µg); CTB – purified CTB standard - 50 ng; BSA - 50ng). 
 
 
Detection of pore formation in red blood cell membranes by purified CTB-ESAT6 
protein using Hemolysis assay 
 
 Lettuce expressing CTB-ESAT6 protein is an oral edible vaccine for TB; 
therefore there is no need to perform purification of antigens. Hence, a tag such as 
histidine was not incorporated in the coding sequence. To perform hemolysis assay 
purification of CTB-ESAT6 fusion protein is necessary. Therefore, we purified CTB–
ESAT6 fusion protein from lettuce plants using immunoaffinity purification with CTB 
antibody. Western blot analysis of purified protein detected multiple bands 
corresponding to monomeric 23 kDa, cleaved 15 kDa and aggregates or multimers of 
>23 kDa molecular weight (Fig. 9a). Based on densitometry analysis, upto 40 µg/ml of 
80% pure CTB–ESAT6 was obtained and this concentration was further confirmed by 
ELISA. Silver staining of purified protein showed two protein bands of ~23 kDa and ~15 
kDa (Fig. 9b). Presence of ~15 kDa protein band showed that the cleavage occurred in 
the ESAT6 protein. Purified CTB protein showed band at their corresponding size (Fig. 
9b). Protein band corresponding to CTB-antibody was not detected in silver staining as 
CTB-antibody was cross linked on to the protein A bead support to prevent antibody 
being co eluted with the antigen. The purified CTB-ESAT6 protein was used for 
hemolysis assay. 
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Figure 10: Antibody affinity purification of CTB-ESAT6 
 
(a) Immunoblot analysis to confirm the presence of antigen with CTB   antibody S1, S2, 
S3: CTB standard samples (12.5, 25, 37.5 ng); E1, E2, E3: elution fractions (100, 50, 25 
ng) respectively; B4IP – CTB-ESAT6 protein before purification (10 μg); WT- wild type 
lettuce total leaf protein (10µg). (b) Silver staining after affinity purification of CTB – 
ESAT6. C1, C2, C3, C4: purified CTB standards (100,200,300,400 ng); after affinity 
(a) 
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purification, elution fractions of CTB-ESAT6 (LS) - E1 (400 ng), E2 (200 ng).     M – 
Protein standard marker 0.4µl.  
 MTB uses ESX-1 secretion system to export virulence proteins during infection. 
ESAT-6 is one of the secreted proteins in ESX-1 system and has been reported to play 
a role in the escape of Mycobacterium from the phagolysosome (van der Wel et al. 
2007) by membrane pore formation (Smith et al. 2008). Purified ESAT-6 has been 
proven to cause dose dependent hemolysis in red blood cells by membrane pore 
formation (Smith et al. 2008). The red blood cell lysis by pore forming proteins occurs by 
osmotic shock. The hemolytic effect of plant-derived partially purified ESAT6 was 
investigated on red blood cell membranes. Hemolysis was measured by the absorbance 
(O.D.) of the red blood cell supernatant which contains lysed cell hemoglobin. Partially 
purified CTB-ESAT6 when solubilized resulted in dose dependent hemolysis. CTB–
ESAT6 formed aggregates in its native form and hence was solubilized to dissociate the 
oligomeric protein into its monomer form. Purified protein without solubilisation did not 
cause hemolysis at a concentration of 40 µg/ml (Fig. 10). After solubilisation, CTB–
ESAT6 at 40 µg/ml protein concentration caused partial hemolysis (45%) of red blood 
cells with an absorbance of 0.85. Decrease in absorbance to 0.4 (21%) was observed 
when the protein was diluted two fold (Fig.10). This indicated that the fusion did not 
modify  ESAT-6 protein ability to form pores and lysed red blood cell membranes in a 
dose-dependent manner. Red blood cells incubated with water resulted in complete 
lysis (absorbance of 1.9) as the cells swell and burst due to movement of water into 
cells. Red blood cells incubated in PBS solution were intact and therefore no 
absorbance was detected (Fig. 10). Complete hemolysis of red blood cell membranes 
was not accomplished with solubilized purified CTB-ESAT6 protein as higher 
concentrations (>40 µg/ml) could not be achieved by affinity purification. 
 
 
Percent hemolysis was calculated using the above formula. 
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Figure 11 :  Hemolysis assay to determine functionality of ESAT-6 in partially purified 
fusion protein CTB-ESAT6  
 H20 – distilled water; E1- CTB-ESAT6 – partially purified protein 40 µg/ml ; E2 – CTB-
ESAT6 – partially purified protein 20 µg/ml; PBS – control;   Elution/sol buffer – elution 
buffer used for protein elution/solubilisation; Nonsol E1 – CTB – ESAT6 (Ls) before 
solubilisation. CTB – purified protein 40 µg/ml; 
 
Lyophilization studies for storage of CTB- ESAT6 oral vaccine 
 
 We performed lyophilization of CTB–ESAT6 expressing lettuce leaves for stable 
storage and discovered that the amount of antigen per gram of leaf material increased. 
After lyophilization, leaves were reduced to 5-8% of their fresh weight thereby 
increasing the CTB-ESAT6 antigenic content per gram of leaf material. Analysis of 
lyophilized material on immunoblots with anti-CTB antibody revealed same protein 
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bands as obtained with fresh leaf material (Fig. 11). There was a 22 fold increase in 
antigenic content per gram in lyophilized leaves when compared to fresh leaves.  
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Figure 12 : Lyophilization studies - Immunoblot analysis of comparison of fresh weight 
and lyophilized material.  
(a) CTB – ESAT6 Protein loaded in equal concentration as both fresh weight and 
lyophilized tissue material. (b) Effect of lyophilized tissue for storage: Immunoblot 
analysis at time point T0 immediately after lyophilization and 6 months after 
lyophilization at time point T6 months. 
(a) 
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 Effect of lyophilization on the binding ability of CTB-ESAT6 fusion protein was 
also tested with GM-1 ELISA binding assay. An extract from CTB-ESAT6 lyophilized 
lettuce leaves effectively bound to the GM1-ganglioside receptors (Fig. 7). Further, 
serial dilution of extract from fresh, lyophilized leaves and purified CTB showed 
decrease in absorbance accordingly (Fig. 7). GM1 binding of CTB-ESAT6 fusion protein 
from lyophilized and fresh lettuce leaves indicates that the CTB in the fusion protein has 
retained its native pentameric structure and has not been disrupted by its fusion to 
ESAT-6 or by lyophilization process. Binding to GM1 receptor is essential for antigen 
uptake in the gut. 
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Figure 13: GM1 ELISA comparison between lyophilized and fresh tissue 
Equal volume loaded at equal concentrations of TSP (15µg) with decreasing dilutions 
gave similar trend. Purified CTB – 10 ng. WT – untransformed TSP (15µg) 
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DISCUSSION 
 
 Recent developments in genetic engineering have revealed enormous potential 
in plant chloroplasts such as high expression, cost-effectiveness, scalability and safety 
in production systems for recombinant biopharmaceuticals and vaccines ((Ma et al. 
2003; Daniell 2006; Yusibov et al. 2008; Daniell et al. 2009). To my knowledge, this is 
the first report of expression of TB vaccine antigens in chloroplasts. In this study, we 
expressed ESAT-6 ,an attractive candidate antigens for TB vaccine development in 
lettuce chloroplasts. Results exhibit an efficient and stable expression of the 
recombinant fusion protein CTB-ESAT6 and CTB-MTB72F in chloroplasts. The main 
factors that are essential for practical development of oral plant vaccines are sufficient 
expression level of antigens in the system used, adequate amount of dosage (leaf 
material) required for immunization, stability and storage of vaccines apart from efficacy. 
Chloroplast expression system is very well suited for production of TB vaccine antigens 
to achieve all the parameters mentioned above.  
 The CTB–ESAT6 lettuce transplastomic plants have modest expression levels of 
0.75% of total leaf protein (TP). In comparison to established tobacco system, lettuce 
has shown lower expression levels with other antigens (Ruhlman et al. 2010). The 
variation in expression levels of recombinant proteins can be due to many factors 
including nature of protein, plant system, environmental conditions, protein stability in 
chloroplasts and regulatory elements present in expression cassette (Scotti et al. 2011). 
Since lower expression levels of CTB–ESAT6 in lettuce, variation could be due to 
protein stability and production in chloroplasts of lettuce.  
 Our results indicated that CTB–ESAT6 lettuce plants expressed 11.2 µg/g (fresh 
weight mature leaf) of antigen whereas lyophilization increased the yield 22 fold as the 
antigenic content built up to 249 µg/g of lyophilized leaves. Hence large amount of 
transgenic protein is available for oral delivery. In human trials for TB subunit vaccine 
ESAT-6, 50 µg of vaccine antigen was injected intramuscularly (van Dissel et al. 2010). 
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So if 50 µg were to be orally fed, based on quantification of antigenic content, only 200 
mg of lyophilized material would be needed. Lyophilized lettuce expressing hepatitis B 
surface antigen has been successfully used in orally delivered plant vaccine animal 
studies (Pniewski et al. 2011). Therefore, all in vitro functional studies were carried out 
with lettuce plants. 
 Lettuce (Lactuca sativa) was chosen as an alternative to tobacco for expression 
of TB vaccine antigens due to its many advantages such as it being an edible crop, its 
leafy nature and commercial importance. The lettuce CTB-ESAT6 plants showed 
modest expression levels which can be remedied with lyophilization, a process of freeze 
drying. Since lettuce has high water content (95%), it can be freeze dried to a greater 
magnitude than tobacco, potato etc. Lettuce is a relatively easy plant to grow with no 
special conditions except cooler environment and can be grown in a few months from 
sowing. Since it is a leafy vegetable, more antigen could be concentrated by 
lyophilization of leaf tissue. The CTB–ESAT6 protein was stable in lyophilized material 
stored at room temperature for six months. This stability of antigens in plant tissue could 
help in eliminating cold chain during storage and distribution required for conventional 
vaccines.  
 Functional analysis of CTB-ESAT6 fusion protein was performed. The ability of 
CTB to form pentamers allows it to bind to GM-1 Ganglioside receptors and gives it the 
advantage of increased antigen uptake. GM-1 ELISA binding assay revealed the ability 
of CTB–ESAT6 fusion protein to form pentamers and bind to the GM-1 receptors. 
ESAT-6 is a secreted protein that is observed in early mycobacterial infections. Its 
activity has been characterized as a cytolysin that can disrupt lipid bilayers (Hsu et al. 
2003). Hemolysis assay established the ability of partially purified CTB-ESAT6 to create 
partial lysis of red blood cell membranes. Plant derived CTB-ESAT6 has been shown to 
retain its biologically activity and has potential to be an effective oral vaccine. 
 Production of an oral subunit vaccine against tuberculosis in chloroplast is a 
promising strategy to overcome the cost constraints such as production, purification, 
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processing, cold storage, transportation and delivery linked to large vaccination 
campaigns, especially with the increasing TB incidence in some developing countries 
where there is a dire need of such vaccines. Lyophilization can help improve the 
stability of the vaccine for prolonged storage. This could help in improving shelf life of 
antigens.   It is estimated that the costs associated with production and delivery of the 
recombinant proteins in bacterial, insects or mammalian cells is much higher when 
compared to plants (Chebolu et al. 2009). Easy and unlimited scalability of production 
and absence of the viral contamination can make plant-derived biologics economical 
and safer for large-scale production (Goldstein et al. 2004; Yusibov et al. 2008).  
  For oral delivery analysis of this TB vaccine antigen expressed in chloroplast, 
animal studies will be performed in future to test its immunogenicity. Lettuce, an edible 
crop plant is an ideal system for oral delivery of CTB-ESAT6 vaccine antigen. Multistage 
vaccines will be significant against a complex disease such as tuberculosis. As 
chloroplasts have polycistronic mRNA, we have the added advantage of expressing 
multiple TB genes in the chloroplasts. So constructing a vaccine with multiple antigens 
that can target early and late stage tuberculosis can pave the way for future oral TB 
vaccine.  
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